ApexBio established in the Hsinchu Science-based Industrial Park since December 1997, the main products are used biosensor technology to create home care medical device for chronic disease patients to maintain and control their health.  ApexBio successfully became the first IPO listed biotechnology company in 2000.

 

ApexBio was founded to develop into a full range of IVD company and is actively engaged in the research, development, manufacture and sales worldwide. At beginning using biosensor technology to develop a self-testing handheld blood glucose monitoring systems, uric acid, hemoglobin, cholesterol, lactate, ketone, coagulation and multifunctional self-testing systems. ApexBio Products have been approved by CE, FDA, TFDA, CFDA and our manufacturing facilities also have been notified by Taiwan GMP, ISO 9001 & 13485, and FDA.

 

ApexBio is the first biotech company in Taiwan to have both FDA and CE approval, and passed three FDA practical inspection in 2001, 2006, and 2011. Regarding quality management system, ApexBio acquired various certifications such as FDA, CE, CFDA, etc. That’s why ApexBio earns the trust of the clients and have a long-term contract with them.